In experimental animal models, chronic TGF-β1 overexpression may participate in the disease pathology [106,107,108,109], and deficiencies in TGF-β signalling may represent a risk factor for the development of some brain disorders [110,111,112,113,114,115]. This evidence concerns the gene TGFB1 and brain disorder.